The Japan Times - Formerra to Supply Foster Medical Compounds in Europe

EUR -
AED 4.058238
AFN 71.827065
ALL 90.387401
AMD 398.375914
ANG 1.977772
AOA 1014.420427
ARS 1707.560467
AUD 1.623598
AWG 1.98906
AZN 1.884164
BAM 1.949007
BBD 2.2264
BDT 137.495104
BGN 1.931411
BHD 0.417058
BIF 3342.241075
BMD 1.105033
BND 1.420587
BOB 12.93925
BRL 6.241119
BSD 1.105377
BTN 103.904652
BWP 15.335962
BYN 3.330382
BYR 21658.652946
BZD 2.223211
CAD 1.575192
CDF 2558.152063
CHF 0.923609
CLF 0.02784
CLP 1095.695402
CNY 7.370959
CNH 7.375092
COP 3667.881826
CRC 499.073985
CUC 1.105033
CUP 26.530366
CVE 109.883979
CZK 24.387868
DJF 196.386709
DKK 7.476036
DOP 67.068049
DZD 151.387143
EGP 59.047681
ERN 16.5755
ETB 180.49487
FJD 2.50809
FKP 0.832125
GBP 0.835367
GEL 2.825984
GGP 0.832125
GHS 12.944233
GIP 0.832125
GMD 81.772227
GNF 9793.862669
GTQ 8.446787
GYD 231.269124
HKD 8.668561
HNL 29.724929
HRK 7.479982
HTG 144.839083
HUF 365.709653
IDR 20173.709179
ILS 3.527822
IMP 0.832125
INR 103.949434
IQD 1675.804339
IRR 2106276.372842
ISK 136.615251
JEP 0.832125
JMD 175.109641
JOD 0.783436
JPY 176.55668
KES 143.642883
KGS 96.633944
KHR 4555.245976
KMF 488.424308
KPW 994.529939
KRW 1475.954336
KWD 0.342273
KYD 0.921214
KZT 490.972005
LAK 24875.968069
LBP 98990.946199
LKR 367.608649
LRD 187.92009
LSL 18.424912
LTL 3.262876
LVL 0.668423
LYD 7.128154
MAD 10.888345
MDL 20.163267
MGA 5045.55029
MKD 61.565799
MMK 2320.265419
MNT 3983.538744
MOP 8.930813
MRU 44.706587
MUR 52.334293
MVR 17.011781
MWK 1916.870627
MXN 20.571074
MYR 4.506881
MZN 70.609884
NAD 18.424912
NGN 1488.369162
NIO 40.679313
NOK 10.565964
NPR 166.247045
NZD 1.992823
OMR 0.424904
PAB 1.105477
PEN 3.769065
PGK 5.042515
PHP 70.573506
PKR 305.678232
PLN 4.405381
PYG 6852.332655
QAR 4.029682
RON 5.348546
RSD 117.608664
RUB 91.498051
RWF 1632.952539
SAR 4.171329
SBD 8.940545
SCR 15.377943
SDG 664.677448
SEK 11.081594
SGD 1.42257
SHP 0.828019
SLE 25.309141
SLL 23172.000929
SOS 631.715254
SRD 41.443188
STD 22871.958538
STN 24.41556
SVC 9.672286
SYP 14367.642795
SZL 18.412322
THB 37.466201
TJS 10.197487
TMT 3.867617
TND 3.327302
TOP 2.660655
TRY 55.53377
TTD 7.509031
TWD 36.478922
TZS 2938.969804
UAH 50.231124
UGX 4549.266655
USD 1.105033
UYU 44.805247
UZS 13232.296828
VES 995.072
VND 28376.702976
VUV 132.541962
WST 3.080611
XAF 655.957
XAG 0.022062
XAU 0.00028479873
XCD 2.986408
XCG 1.99221
XDR 0.781316
XOF 655.957
XPF 119.331742
YER 261.341095
ZAR 18.543895
ZMK 9946.661002
ZMW 22.577916
ZWL 355.820276
SSP 6394.301253
MXV 2.310758
  • RYCEF

    0.1000

    19.81

    +0.5%

  • VOD

    -0.2500

    16.33

    -1.53%

  • CMSC

    -0.2800

    20.12

    -1.39%

  • RBGPF

    -2.0000

    65

    -3.08%

  • RIO

    -0.2500

    94.16

    -0.27%

  • BTI

    -1.2000

    54.85

    -2.19%

  • NGG

    -0.3000

    74.94

    -0.4%

  • GSK

    -0.3500

    49.35

    -0.71%

  • BCE

    -0.4200

    20.14

    -2.09%

  • CMSD

    -0.3400

    19.93

    -1.71%

  • BP

    -0.9100

    43.52

    -2.09%

  • RELX

    0.1700

    33.24

    +0.51%

  • BCC

    -0.6200

    75.97

    -0.82%

  • AZN

    -1.9400

    164.21

    -1.18%

  • JRI

    0.0000

    10.77

    0%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

T.Shimizu--JT